Impact of glycaemic status on the subgingival microbiome in diabetes

Summarised from:

Glycaemic status affects the subgingival microbiome of diabetic patients
(Journal of Clinical Periodontology; doi: 10.1111/jcpe.12908)

Authors:

Priscila L. Longo, Shareef Dabdoub, Purnima Kumar, Hilana P. C. Artese, Sergio A. Dib, Giuseppe A. Romito, Marcia Pinto Alves Mayer

Summarised by:

Dr Varkha Rattu

Research Topic:

Background + Aims

  • The human microbiome plays a vital role in health, with links between gut microbiota and metabolic disorders like type 2 diabetes mellitus (T2DM).
  • The oral microbiota, particularly the subgingival microbiome, is thought to be influenced by diabetes.
  • Chronic periodontitis (CP) is more common in patients with diabetes, and their subgingival microbiota is thought to differ from patients without diabetes, harbouring higher levels of pathogens such as Porphyromonas gingivalis and Tannerella forsythia.
  • It has been hypothesised that poor glycaemic control can alter microbial composition in periodontal pockets, with elevated HbA1c levels creating a glucose-rich gingival environment that may further challenge the subgingival microbiota.
  • This study explores the subgingival microbiome of CP patients with varying glycaemic status.

Materials + Methods

  • The study included 21 T2DM patients (HbA1c > 6.5%) diagnosed for ≥3 years and prescribed oral hypoglycaemic medication.
  • Participants were recruited from endocrinology clinics and underwent oral examinations at the University of São Paulo, Brazil.
  • Inclusion criteria were:
    • Age ≥40 years old
    • ≥15 natural teeth
    • Severe periodontitis – ≥30% of sites with probing depth (PD) ≥4 mm and ≥20 sites with PD >6 mm.
  • Exclusion criteria included:
    • HIV
    • Hepatitis
    • Cancer history
    • Smoking
    • Alcohol use
    • Pregnancy
    • Morbid obesity (BMI ≥40 kg/m²).
  • HbA1c levels were measured 15 days before plaque sample collection, classifying patients into 2 groups:
    • Adequate glycaemic control (DMA) (HbA1c <7.8%, DMA group, n=11)
    • Inadequate control (DMI) (HbA1c ≥8%, DMI group, n=10)
  • Subgingival biofilm samples were collected from moderate (PD 4–6 mm) and deep pockets (PD ≥7 mm) using mini-five Gracey curettes.
    • Samples were pooled by pocket depth, transferred to TE buffer, frozen at −80°C, and subjected to DNA extraction using the Master Pure DNA Extraction Kit.
  • Bacterial profiles were assessed using 16S rRNA sequencing. Shannon diversity and equitability indices described diversity within samples, while UniFrac-based analyses compared bacterial community membership between groups.

Results

  • The study analysed subgingival microbiota in 21 T2DM patients with adequate (DMA) and inadequate (DMI) glycaemic control. Despite similar clinical periodontal parameters, the two groups differed significantly in HbA1c levels (p < 0.001).
  • Of 42 pooled samples, five from deep pockets were excluded because they yielded too few sequencing reads, leaving 37 pooled samples from the 21 participants.
  • Microbial analyses revealed that:
    • Bacterial community composition differed between the adequate and inadequate glycaemic-control groups (ANOSIM p = .022; Adonis p = .042). The authors also reported higher microbial diversity in the adequate-control group, based on the distribution of bacterial species-level groups. The reported ANOSIM and Adonis p-values concern community differences rather than a direct comparison of within-sample diversity.
    • The Firmicutes/Bacteroidetes ratio was comparable between groups, and periodontopathogens such as P. gingivalis and T. forsythia were prevalent in both groups, showing no significant differences.
    • At the phylum level (the broadest taxonomic classification within bacterial taxonomy), the study found that subgingival samples from DMI patients had a significantly lower abundance of Tenericutes compared to DMA patients.
    • DMA patients demonstrated higher levels of Alphaproteobacteria (a class within Proteobacteria), and Eubacteriaceae, Lachnospiraceae, and Peptostreptococcaceae (Firmicutes families).
    • DMI presented with lower proportions of certain Treponema species and exhibited higher levels of certain Prevotellaceae species within Bacteroidetes but lower levels of other phylotypes.
    • No significant differences were found for Fusobacteria, Synergistetes, or Actinobacteria between groups, though slight differences inCoriobacteriaceae and Atopobium levels were observed.

Limitations

  • The small sample size limits the generalisability of the findings, and larger studies are needed to confirm the observed differences in subgingival microbiota between patients with adequate (DMA) and inadequate (DMI) glycaemic control.
  • The study could not account for the long-term effects of oral hypoglycaemic medications, particularly metformin, on the oral microbiota.
  • The study relied on 16S rRNA sequencing to identify bacterial groups. Proposed differences in metabolic activity were inferred from the bacteria identified; functional activity was not measured directly.
  • Functional gene-based analyses are required to better understand how glucose availability impacts the subgingival microbiota’s metabolic activity.
  • Specific metabolic by-products, including short-chain fatty acids (SCFAs), were not measured. The proposed changes in metabolite production therefore require confirmation.

Conclusion

  • In this small observational study, poorer glycaemic control was associated with differences in the bacteria beneath the gums and lower diversity as reported by the authors. The study could not establish whether glucose levels caused these differences or whether they affected periodontal disease progression or treatment response.
  • Further research is needed to explore the impact of metabolic challenges on the oral microbiome and the implications for periodontal treatment outcomes in diabetic patients.
Read the full article Back to Research

Research  |  09.05.18

clock icon 8 mins to read

Share this page:

Copy Link

You might also like...

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on…

Read more

Events

Periodontitis-Diabetes Hub x #DiabetesChat

Hosted by #diabeteschat, join Dr Varkha Rattu and the team behind the Periodontitis-Diabetes Hub for an insightful discussion exploring the importance of managing periodontitis and diabetes.

Read more

Events

Oral Health Challenges Among People Living With Diabetes

Dr Antoniszczak will present a lecture about the oral health challenges among people living with diabetes. This lecture explores the key challenges faced by individuals living with diabetes, focusing on the relationship between diabetes and oral health.

Read more
icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

icon1 services

Periodontitis is the 6th most prevalent condition globally

icon1 services

Periodontitis and diabetes are bidirectionally linked

icon1 services

Diabetic complications are increased if you have both diseases

icon1 services

Successful periodontal treatment can improve blood glucose control

Events

20.11.26

Bangalore, India

Oral Health and Diabetes

A four-day scientific programme featuring nearly 200 sessions, encompassing prestigious orations, state-of-the-art lectures, thought-provoking debates,…

Read more
VIEW ALL

Our Team

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Education & Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Outreach & Communications Lead

Team - The Periodontitis-Diabetes Hub

Dr Varkha Rattu

Periodontitis-Diabetes Hub Position: Founder & Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Amar Puttanna

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Rajeev Raghavan

Periodontitis-Diabetes Hub Position: Diabetes Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Mark Ide

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Professor Luigi Nibali

Periodontitis-Diabetes Hub Position: Periodontology Co-Lead

Team - The Periodontitis-Diabetes Hub

Dr Dominika Antoniszczak

Periodontitis-Diabetes Hub Position: Education and Support Advisor

Team - The Periodontitis-Diabetes Hub

Dr Jasmine Loke

Periodontitis-Diabetes Hub Position: Clinical Content Advisor

Team - The Periodontitis-Diabetes Hub

Dr Mira Shah

Periodontitis-Diabetes Hub Position: Patient Resource Advisor

Team - The Periodontitis-Diabetes Hub

Elaine Tilling

Periodontitis-Diabetes Hub Position: Outreach and Communications Lead

View All